Sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway

PURPOSE: The mechanism of sodium–glucose cotransporter-2 inhibitor (SGLT-2i) reducing the incidence of atrial fibrillation remains unclear. We hypothesize that sodium–glucose cotransporter-2 inhibitor alleviated atrial remodeling in STZ-induced diabetic rats by targeting TLR4 pathway. METHODS: A tot...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhan, Xiaoping, Cheng, Lijun, Huo, Ning, Yu, Lin, Liu, Changle, Liu, Tong, Li, Guangping, Fu, Huaying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485554/
https://www.ncbi.nlm.nih.gov/pubmed/36148071
http://dx.doi.org/10.3389/fcvm.2022.908037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9485554/
https://www.ncbi.nlm.nih.gov/pubmed/36148071
http://dx.doi.org/10.3389/fcvm.2022.908037

Ejemplares similares